The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development

Area of Science:

• Oncology and Immunology

Background:

• Cancer's evasion of immune destruction is a key characteristic.
• Chronic inflammation promotes immune escape and tumor development.
• The tumor microenvironment can hinder anti-cancer treatments.

Purpose of the Study:

• To review the relationship between inflammation and immunosuppression in cancer.
• To examine their impact on the tumor microenvironment.
• To discuss implications for immune checkpoint inhibitor therapy and biomarkers.

Main Methods:

• Literature review of inflammation, immunosuppression, and cancer.
• Analysis of tumor microenvironment dynamics.
• Exploration of immune checkpoint inhibitor mechanisms and biomarkers.

Main Results:

• Inflammation and immunosuppression create a tumor microenvironment that supports cancer growth.
• These processes can reduce the effectiveness of immune checkpoint inhibitors.
• Predictive biomarkers are crucial for optimizing therapy.

Conclusions:

• Understanding the interplay of inflammation and immunosuppression is vital for cancer treatment.
• Targeting these pathways may enhance anti-tumor immunity.
• Biomarker development is essential for personalized immune checkpoint inhibitor therapy.